TESOFENSINE™

ADVANCED METABOLIC PATHWAY RESEARCH, DEFINED BY PRECISION.

A focused capsule presentation centered on appetite-related signaling, metabolic pathways, and advanced neurochemical research.

What it is

TESOFENSINE™ features a research-stage compound studied for its interaction with serotonin, norepinephrine, and dopamine signaling pathways. Tesofensine has been evaluated in randomized Phase 2 clinical research

involving adults with obesity, with additional studies examining its use alongside metoprolol. A precise, minimalist format created for those who value scientific specificity over conventional supplement trends.

Composition / matrix

Tesofensine — 500 mcg (visible en la imagen del producto, pág. 21)

Focus / benefits

Studied in connection with:

Appetite-related signaling pathways Serotonin, norepinephrine, and dopamine activity Metabolic-response mechanisms Food-intake regulation research Advanced weight-management science

The Molekula difference

Not another mass-market metabolism capsule. Precision without distraction. Focused single-compound presentation. Clearly identified active ingredient. Research-informed formulation concept.

No conventional caffeine positioning. Minimalist capsule delivery. Designed around scientific precision—not marketing clutter. Created for individuals who expect clarity, sophistication, and a more advanced standard of formulation.

Presentation

90 Tablets (visible en la imagen del producto, pág. 21)

Warnings

Tesofensine is an investigational compound and is not FDA-approved for general consumer use in the United States. For research purposes only.